The Transformation of Locally Advanced Pancreatic Cancer.
Status:
Not yet recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
This trial will explore the efficacy and safety of camrelizumab combined with apatinib
mesylate and radiotherapy and chemotherapy (paclitaxel (albumin binding) combined with
gemcitabine and cisplatin) in the treatment of locally advanced pancreatic cancer in patients
with locally advanced pancreatic cancer.